Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P850064/S055

LifePulse High Frequency Ventilator (HFV)

Bunnell, Inc. · Decision date Jul 25, 2025

FDA DECISIONP850064/S055

What did the FDA approve?

FDA records P850064/S055 as a supplement to PMA P850064, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Jul 25, 2025.

FDA approval order statement

for a change to materials in the Patient Circuit based on their biocompatibility profile. The changes include: a change to circuit tubing material (no change to tubing type or dimensions), change in the anodization process of the heater cup, and replacing the adhesives used with medical grade adhesives.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Anesthesiology
Decision date
Jul 25, 2025
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P850064/S055
Regulatory pathway
PMA supplement
Applicant
Bunnell, Inc.
Product code
LSZ
Decision code
APPR
Decision date
Jul 25, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: VENTILATOR, HIGH FREQUENCY.

Applicant
Bunnell, Inc.
Product code
LSZ
FDA device class
3

For the original device and its historical approval scope, see PMA P850064. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P850064 · Original PMA

    MODEL 203 LIFE PULSE HIGH FREQUENCY VENTILATOR

  2. P850064/S055 received

    Application receipt date recorded by FDA.

  3. P850064/S055 · FDA decision

    Real-Time Process

  4. P850064/S058 · Related supplement

    LifePulse High Frequency Ventilator (LifePulse HFV) Model 204

  5. P850064/S056 · Related supplement

    LifePulse High Frequency Ventilator

Timeline entries are records held by MedtechLedger for P850064. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P850064

Product / regulatory recordCompanyPathwayDecision dateSource
Bunnell, Inc.PMA approvalJun 30, 1988FDA
Bunnell, Inc.PMA supplementMay 7, 2026FDA
Bunnell, Inc.PMA supplementSep 28, 2026FDA

Explore the linked device profile

Other records with product code LSZ

Product / regulatory recordCompanyPathwayDecision dateSource
ZOLL MEDICAL CORPORATIONPMA supplementJul 23, 2025FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Bunnell, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
436 Lawndale Dr., Salt Lake City, UT, 84115

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records